Fmoc-3-Fluoro-D-Phenylalanine

Fmoc-3-Fluoro-D-Phenylalanine is an Fmoc-protected D-phenylalanine derivative bearing a fluorine substituent at the 3-position of the aromatic ring. The molecule combines a chiral, stereodefined amino acid backbone with a stable aromatic fluorine handle that can influence conformation, electronic properties, and metabolic stability trends in downstream analogs. The Fmoc group on the alpha-amino function supports standard base-labile protection for stepwise peptide assembly, while the carboxyl functionality is configured for peptide coupling chemistry typical of protected amino acid building blocks. The aryl C-F bond provides a chemically robust yet synthetically informative site for structure-guided derivatization and for generating fluorinated peptidomimetics and SAR-focused libraries.

1. Peptide Synthesis

Fmoc-3-Fluoro-D-Phenylalanine is used in peptide building block workflows for solid-phase peptide synthesis and related protected amino acid chemistry. The Fmoc-protected D-amino stereocenter enables controlled incorporation of a D-residue into peptide chains, supporting studies of backbone stereochemistry, protease resistance, and conformational bias. The aromatic 3-fluoro substituent remains intact under common Fmoc deprotection and peptide coupling conditions, allowing fluorinated peptide analogs to be assembled without losing the structural marker. The resulting fluorinated D-amino acid-containing peptides can be carried forward to purification, analytical characterization, and iterative analog design, aligning with peptide science and synthetic methodology needs.

2. Peptidomimetics And SAR

Fmoc-3-Fluoro-D-Phenylalanine supports medicinal chemistry-oriented peptidomimetic construction where fluorinated aromatic side chains are used to tune electronic distribution and binding-site interactions. The D-configuration at the alpha-carbon provides a stereochemical lever for controlling peptide-like folding and for probing stereospecific recognition in structure-activity relationship studies. The 3-fluoro aryl group functions as a persistent substituent for SAR mapping, enabling systematic variation of fluorination patterns while maintaining the same protected amino acid backbone. Downstream, the residue can be incorporated into constrained analogs, stapled or cyclized frameworks, and fragment-based peptide mimetics that serve as research intermediates for lead optimization campaigns and structure-guided library generation.

3. Chemical Biology Probes

Fmoc-3-Fluoro-D-Phenylalanine is applicable to chemical biology research requiring fluorinated amino acid analogs for molecular recognition and labeling strategies. The Fmoc-protected amine enables incorporation into peptide tags and recognition elements using standard peptide coupling chemistry, while the D-configuration can help modulate stability and reduce enzymatic processing in probe constructs. The aryl fluorine can serve as a spectroscopic handle for NMR-based tracking or as a design element for affinity tuning in biomolecule-interacting peptides. The resulting fluorinated peptide probes can be used to generate biomolecule interaction tools, enabling downstream conjugation to carriers or surfaces through functional group chemistry introduced at other positions of the construct.

4. Side-Chain Functionalization

Fmoc-3-Fluoro-D-Phenylalanine is suitable for synthetic organic chemistry routes that leverage an aryl fluorine substituent as a controlled modification site during downstream derivatization. The protected amino acid format allows the residue to be handled as a chiral intermediate for sequential transformations, including selective deprotection and subsequent functional group installation on the peptide scaffold. The aromatic C-F bond can be retained during early peptide assembly steps and then used to guide later scaffold diversification, such as generating fluorinated analog series or enabling cross-coupling-compatible design logic when additional functional groups are introduced elsewhere. The D-stereocenter further supports stereochemically defined intermediates for building chiral fluorinated motifs used in fine chemical synthesis and research-grade library production.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-3-Fluoro-D-Phenylalanine is relevant to pharmaceutical manufacturing workflows that require consistent, stereodefined protected amino acid inputs for fluorinated peptide intermediate preparation. The Fmoc protection strategy supports scalable peptide coupling sequences, where base-labile deprotection can be integrated into controlled process steps for producing fluorinated D-amino acid-containing intermediates. The stable aryl fluorine substituent allows manufacturing routes to maintain a defined structural feature through protected amino acid handling, coupling, and purification stages. The resulting fluorinated peptide fragments can serve as upstream intermediates for further derivatization, including conversion into larger peptide drug candidates, process-scale reference materials, and analytical standards used to support batch characterization and method development.

6. Analytical Research Standards

Fmoc-3-Fluoro-D-Phenylalanine is used in analytical research for preparing fluorinated peptide standards and chiral reference materials. The combination of Fmoc protection and D-stereochemistry supports reproducible incorporation into defined peptide sequences, enabling consistent analytical behavior in LC-MS, NMR, and chromatographic method validation contexts. The 3-fluoro aromatic motif provides a distinctive structural marker that can improve traceability of fluorinated analogs during method development and impurity profiling. The residue can be employed to generate well-defined intermediates for calibration, identity confirmation, and stereochemical studies, supporting robust analytical research and quality-oriented characterization of fluorinated peptide libraries.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

3. Myotropic activity of allatostatins in tenebrionid beetles

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics